According to the SEC Form 4 filings, Tatsis Ourania, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $6,513,287 | 8 | 100 |
| 2026-07-02 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 1,500 0.0006% | $524.99 | $787,485 | -2.5% | |
| 2026-02-25 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 260 0.0001% | $486.35 | $126,451 | -0.6% | |
| 2026-02-18 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 368 0.0001% | $473.68 | $174,314 | +2.1% | |
| 2026-02-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 609 0.0002% | $489.46 | $298,081 | +0.59% | |
| 2026-02-13 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 1,500 0.0006% | $499.99 | $749,985 | -2.31% | |
| 2026-02-11 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 466 0.0002% | $460.43 | $214,560 | +4.1% | |
| 2026-01-07 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 4,500 0.0017% | $474.99 | $2.14M | -1.51% | |
| 2025-12-03 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 4,500 0.0017% | $449.99 | $2.02M | +1.62% | |
| 2025-03-10 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 3,242 0.0013% | $499.99 | $1.62M | -10% | |
| 2025-03-04 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 4,058 0.0016% | $485.49 | $1.97M | -7.44% | |
| 2025-02-27 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 530 0.0002% | $475.34 | $251,930 | -5.16% | |
| 2025-02-25 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 354 0.0001% | $480.95 | $170,256 | -6.31% | |
| 2025-02-18 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 244 <0.0001% | $455.06 | $111,035 | -2.61% | |
| 2025-02-11 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 310 0.0001% | $459.83 | $142,547 | -1.14% | |
| 2024-06-03 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 2,175 0.0008% | $460.00 | $1M | +0.93% | |
| 2024-05-31 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 2,250 0.0009% | $445.00 | $1M | +4.22% | |
| 2024-05-30 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 2,350 0.0009% | $439.11 | $1.03M | +7.11% | |
| 2024-02-26 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 354 0.0001% | $425.70 | $150,698 | +7.29% | |
| 2024-02-21 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 360 0.0001% | $421.77 | $151,837 | +10.7% | |
| 2024-02-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Reg. & Quality Off. | 480 0.0002% | $420.79 | $201,979 | +10.34% |